[ad_1]
Lumen Technologies Inc.’s high-yield bonds have rallied along with the sharp spike in its stock price this week, but one analyst says they are still too risky.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...